Pyxant Labs is a regulated bioanalytical contract research organization that produces bioanalytical data for pharmaceutical companies using mass spectrometry. In doing this, Pyxant Labs plays a key role in researching, developing, and testing new drug compounds to bring to market.
Client Description
Pyxant Labs is a regulated bioanalytical contract research organization that produces bioanalytical data for pharmaceutical companies using mass spectrometry. In doing this, Pyxant Labs plays a key role in researching, developing, and testing new drug compounds to bring to market.
Client Challenges
Labcorp, one of the largest clinical laboratory networks in the world, spun off a division in Salt Lake City that was acquired by Pyxant Labs. One of the tools the company leverages is Watson, an application that provides a comprehensive report after running a sample.With an additional lab location, Pyxant Labs needed to decide how to approach Watson, as installing it on the premises in Salt Lake city would have required the company to purchase a separate set of licenses, the cost of which were a point of concern.
Stefanini Solutions
Stefanini has had a team of close to 300 workers globally supporting Labcorp since 2013. With this baseline understanding of Labcorp’s infrastructure, Stefanini’s enterprise team studied Pyxant Labs’ data, processes, and infrastructure to quickly understand where they wanted to go. To aid in this process, Stefanini provided specialized applications to meet Pyxant’s needs.
Results
The merger integration provided by Stefanini streamlined Pyxant’s acquisition of the Salt Lake City Labcorp division, allowing the two teams to seamlessly integrate and begin taking strides forward.
As collaborators and co-creators, Stefanini has continued to serve Pyxant Labs as an ongoing partner.
CLIENT TESTIMONIES
– Maurice Gaubatz, Founder of Pyxant Labs
“I’m still not quite sure why Stefanini devotes the amount of attention and goodwill and high-quality service to us, at a really good value point, when they also have customers such as Fortune 100 companies,
[but] I’m happy they do, and I think and hope it’s a mutually beneficial partnership.”